PARP1 and myelodysplastic syndrome: PARP1 inhibition leads to ‘preservation’ of DNA damage that would have otherwise been repaired by the base excision repair (BER) system and to dysfunction of the malignant cell, although there is evidence that BER dysfunction may explain one aspect of the propensity to chromosomal breaks in some patients with MDS.18